Hydrochloride drug formulations
Pro Research Analysisby 
Searched over 200M research papers
Hydrochloride Drug Formulations: Types and Approaches
Hydrochloride drug formulations are widely used to improve the solubility, stability, and bioavailability of various medications. Recent research highlights several innovative formulation strategies for different hydrochloride drugs, each tailored to address specific therapeutic needs and drug properties.
Sustained and Controlled Release Hydrochloride Formulations
Many hydrochloride drugs benefit from sustained or controlled release systems, which help maintain therapeutic drug levels and reduce dosing frequency. For example, bilayer tablets of ropinirole hydrochloride combine immediate-release and sustained-release layers, resulting in improved drug release profiles and stability compared to marketed products . Similarly, mebeverine hydrochloride sustained-release capsules, prepared using pelletization and ethylcellulose as a rate-controlling polymer, achieve prolonged drug release over 12 hours, enhancing patient compliance and reducing side effects . FDM 3D-printed gastric-floating formulations of verapamil hydrochloride also demonstrate the ability to control drug release by adjusting the shape and infill percentage of the printed dosage forms .
Enhancing Bioavailability with Advanced Delivery Systems
Improving the bioavailability of poorly absorbed hydrochloride drugs is a key focus. Solid-lipid nanoparticles (SLNs) loaded with diltiazem hydrochloride show enhanced bioavailability and sustained drug release over 24 hours, outperforming conventional marketed preparations . For loperamide hydrochloride, a self-microemulsifying drug delivery system (SMEDDS) significantly increases solubility and dissolution rate, achieving complete drug release within 30 minutes and demonstrating good stability . Metformin hydrochloride formulated as mucoadhesive microspheres and nanoparticles provides sustained release, improved bioavailability, and potential anticancer effects, with drug release primarily governed by diffusion mechanisms .
Mucoadhesive and In Situ Gelling Formulations
Mucoadhesive and in situ gelling systems are designed to enhance drug residence time and absorption at the site of administration. Tamsulosin hydrochloride in a nasal in situ gelling formulation shows much higher bioavailability compared to oral solutions, with prolonged mucosal adhesion and sustained drug release . Carteolol hydrochloride formulated as an environmentally responsive ophthalmic gel increases ocular bioavailability and reduces systemic side effects, with drug release modulated by polymer and drug concentrations . Propranolol hydrochloride buccal emulgel, using gellan gum and permeation enhancers, achieves high drug permeability and stable, controlled release suitable for buccal delivery .
Pediatric and Patient-Friendly Formulations
For pediatric use, oral liquid formulations of hydrochloride drugs are essential. A new oral liquid formulation of nicardipine hydrochloride, using simple and safe excipients, maintains drug stability and uniformity for up to a year, providing a reliable option for treating pediatric hypertension .
Conclusion
Hydrochloride drug formulations employ a variety of advanced delivery systems—such as sustained-release tablets, nanoparticles, microemulsions, mucoadhesive gels, and pediatric liquids—to optimize drug release, enhance bioavailability, and improve patient outcomes. These innovations address the unique challenges of each drug, offering more effective and patient-friendly therapeutic options 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic